Determination of steroid metabolome as a possible tool for laboratory diagnosis of schizophrenia

Journal of Steroid Biochemistry and Molecular Biology

Volumn 133, Issue 1, 2013, Pages 77-83

  Bicikova, Marie ^a   Hill, Martin ^a   Ripova, Daniela ^b   Mohr, Pavel ^b   Hampl, Richard ^a  

^a INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

Author keywords

First episode; Metabolome; Neuroactive steroids; Schizophrenia

Indexed keywords

16ALPHA HYDROXYPREGNENOLONE; 17 HYDROXYPREGNENOLONE; 3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 3BETA HYDROXY 5BETA PREGNAN 20 ONE; AMISULPRIDE; ANDROSTANEDIOL; ANDROSTANOLONE; ANDROSTENEDIOL; ANDROSTENEDIONE; ANDROSTERONE; ATYPICAL ANTIPSYCHOTIC AGENT; EPIANDROSTERONE; EPIETIOCHOLANOLONE; ETIOCHOLANOLONE; HYDROCORTISONE; NEUROSTEROID; OLANZAPINE; PRASTERONE; PREGN 5 ENE 3BETA,20ALPHA DIOL; PREGNENOLONE; PREGNENOLONE DERIVATIVE; PREGNENOLONE SULFATE; PROGESTERONE; PYROGEN; RISPERIDONE; SEPRANOLONE; STEROID; SULFATASE; TESTOSTERONE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; LABORATORY DIAGNOSIS; MALE; MASS FRAGMENTOGRAPHY; METABOLITE; METABOLOME; METABOLOMICS; PATHOPHYSIOLOGY; PREDICTIVE VALUE; SCHIZOPHRENIA; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; STEROID BINDING; STEROID BLOOD LEVEL; STEROID METABOLISM;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; METABOLOME; METABOLOMICS; MIDDLE AGED; MODELS, BIOLOGICAL; SCHIZOPHRENIA; STEROIDS; SULPIRIDE; YOUNG ADULT;

EID: 84867015451     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2012.08.009     Document Type: Article

References (39)

1. E.E. Baulieu Neurosteroids: of the nervous system by the nervous system, for the nervous system. Recent Prog Hormone Research 52 1997 1 32
2. D.S. Reddy Pharmacology of endogenous neuroactive steroids Critical Reviews in Neurobiology 15 2003 197 234
3. B.O. Dubrovsky Steroids neuroactive steroids and neurosteroids in psychopathology Progress in Neuro-Psychopharmacology and Biological Psychiatry 29 2005 169 192
4. C.E. Weaver, M.B. Land, R.H. Purdy, K.G. Richards, T.T. Gibbs, and D.H. Farb Geometry and charge determine pharmacological effects of steroids on N-methyl-d-aspartate receptor-induced Ca(2+) accumulation and cell death Journal of Pharmacology and Experimental Therapeutics 293 2000 747 754
5. N.A. Compagnone, and S.H. Mellon Neurosteroids: biosynthesis and function of these novel neuromodulators Frontiers in Neuroendocrinology 21 2000 1 56
6. D. Eser, T.C. Baghai, C. Schüle, C. Nothdurfter, and R. Rupprecht Neuroactive steroids as endogenous modulators of anxiety Current Pharmaceutical Design 14 2008 3525 3533
7. D. Eser, E. Romeo, T.C. Baghai, F. Di Michaele, C. Schüle, A. Pasini, P. Zwanzger, F. Padberg, and R. Rupprecht Neuroactive steroids as modulators of depression and anxiety Neuroscience 138 2006 1041 1048
8. C. Schüle, D. Eser, T.C. Baghai, C. Nothdurfter, J.S. Kessler, and R. Rupprecht Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs Neuroscience 191 2011 55 77
9. R.M. Kaminski, H. Marini, W.J. Kim, and M.A. Rogawski Anticonvulsant activity of androsterone and etiocholanolone Epilepsia 46 2005 819 827
10. A receptors J Journal of Pharmacology and Experimental Therapeutics 334 2010 1031 1041
11. D.S. Reddy Neurosteroids: endogenous role in the human brain and therapeutic potentials Progress in Brain Research 186 2010 113 137
12. A receptor function through distinct sites Brain Research 830 1999 72 87
13. M. Park-Chung, F.S. Wu, and D.H. Farb 3 alpha-Hydroxy-5 beta-pregnan-20-one sulfate: a negative modulator of the NMDA-induced current in cultured neurons Molecular Pharmacology 46 1994 146 150
14. M. Park-Chung, F.S. Wu, R.H. Purdy, A.A. Malayev, T.T. Gibbs, and D.H.D. Farb Distinct sites for inverse modulation of N-methyl-d-aspartate receptors by sulfated steroids Molecular Pharmacology 52 1997 1113 1123
15. C.L. Kussius, N. Kaur, and G.K. Popescu Pregnanolone sulfate promotes desensitization of activated NMDA receptors Journal of Neuroscience 29 2009 6819 6827
16. D.N. D'Souza, R.E. Harlan, and M.M. Garcia Modulation of glutamate receptor expression by gonadal steroid hormones in the rat striatum Brain Research Bulletin 59 2003 289 292
17. J.A. Fishback, M.J. Robson, Y.T. Xu, and R.R. Matsumoto Sigma receptors: potential targets for a new class of antidepressant drug Pharmacology and Therapeutics 127 2010 271 282
18. M. Martina, M.E. Turcotte, S. Halman, and R. Bergeron The sigma-1 receptor modulates NMDA receptor synaptic transmission and plasticity via SK channels in rat hippocampus The Journal of Physiology 578 2007 143 157
19. T.P. Su, E.D. London, and J.H. Jaffe Steroid binding at sigma receptors suggests a link between endocrine nervous, and immune systems Science 240 1988 219 221
20. T. Maurice, and T.P. Su The pharmacology of sigma-1 receptors Pharmacology and Therapeutics 124 2009 195 206
21. M.G. Sánchez, M. Bourque, M. Morissette, and T. Di Paolo Steroids-dopamine interactions in the pathophysiology and treatment of CNS disorders CNS Neuroscience and Therapeutics 16 2010 e43 e71
22. M.S. Ritsner Pregnenolone dehydroepiandrosterone, and schizophrenia: alterations and clinical trials CNS Neuroscience and Therapeutics 16 2010 32 44
23. E.M. MacKenzie, J. Odontiadis, J.M. Le Melledo, T.I. Prior, and G.B. Baker The relevance of neuroactive steroids in schizophrenia depression, and anxiety disorders Cellular and Molecular Neurobiology 27 2007 541 574
24. M. Bicikova, M. Hill, D. Ripova, and P. Mohr Altered levels of circulating GABAergic 5 alpha/beta-reduced pregnane and androstane steroids in schizophrenic men Hormone Molecular Biology and Clinical Investigation 6 2011 227 230
25. M. Bicikova, R. Hampl, M. Hill, D. Ripova, P. Mohr, and Z. Putz Neuro- and immunomodulatory steroids and other biochemical markers in drug-naive schizophrenia patients and the effect of treatment with atypical antipsychotics Neuroendocrinology Letters 32 2011 141 147
26. M. Hill, A. Parizek, R. Kancheva, M. Duskova, M. Velikova, L. Kríz, M. Klímková, A. Pasková, Z. Zizka, P. Matucha, M. Meloun, and L. Stárka Steroid metabolome in plasma from the umbilical artery umbilical vein, maternal cubital vein and in amniotic fluid in normal and preterm labor Journal of Steroid Biochemistry and Molecular Biology 121 2010 594 610
27. R. Kaddurah-Daouk Metabolic profiling of patients with schizophrenia PLoS Medicine 3 2006 1 4 e363
28. E. Holmes, T.M. Tsang, J.T. Huang, F.M. Leweke, D. Koethe, C.W. Gerth, B.M. Nolden, S. Gross, D. Schreiber, J.K. Nicholson, and S. Bahn Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia PLoS Medicine 3 2006 1 16 e327
29. M.C. Ryan, N. Sharifi, R. Condren, and J.H. Thakore Evidence of basal pituitary-adrenal overactivity in first episode drug naive patients with schizophrenia Psychoneuroendocrinology 29 2004 1065 1070
30. C.E. Marx, R.D. Stevens, L.J. Shampine, V. Uzunova, W.T. Trost, M.I. Butterfield, M.W. Massing, R.M. Hamer, A.L. Morrow, and J.A. Lieberman Neuroactive steroids are altered in schizophrenia and bipolar disorder: relevance to pathophysiology and therapeutics Neuropsychopharmacology 31 2006 1249 1263
31. M.T. Whittaker, T.T. Gibbs, and D.H. Farb Pregnenolone sulfate induces NMDA receptor dependent release of dopamine from synaptic terminals in the striatum Journal of Neurochemistry 107 2008 510 521
32. P. Gallagher, S. Watson, M.S. Smith, A.H. Young, and I.N. Ferrier Plasma cortisol-dehydroepiandrosterone (DHEA) ratios in schizophrenia and bipolar disorder Schizophrenia Research 90 2007 258 265
33. M. Ritsner, A. Gibel, E. Ram, R. Maayan, and A. Weizman Alterations in DHEA metabolism in schizophrenia: two-month case-control study European Neuropsychopharmacology 16 2006 137 146
34. R.D. Strous Dehydroepiandrosterone (DHEA) augmentation in the management of schizophrenia symptomatology Essential Psychopharmacology l6 2005 141 147
35. E. Fernandez-Egea, B. Miller, C. Garcia-Rizo, M. Bernardo, and B. Kirkpatrick Metabolic effects of olanzapine in patients with newly diagnosed psychosis Journal of Clinical Psychopharmacology 31 2011 154 159
36. C. Garcia-Rizo, E. Fernandez-Egea., A. Justicia, E. Parellada, M. Bernardo, and B. Kirkpatrick Prolactin concentrations in newly diagnosed antipsychotic-naïve patients with nonaffective psychosis Schizophrenia Research 134 2012 16 19
37. T.J. Huber, J. Rollnik, J. Wilhelms, A. von zur Mühlen, H.M. Emrich, and U. Schneider Estradiol levels in psychotic disorders Psychoneuroendocrinology 26 2001 27 35
38. T.J. Huber, C. Tettenborn, E. Leifke, and H.M. Emrich Sex hormones in psychotic men Psychoneuroendocrinology 30 2005 111 114
39. N. Bergemann, C. Mundt, P. Parzer, I. Jannakos, I. Nagl, B. Salbach, K. Klinga, B. Runnebaum, and F. Resch Plasma concentrations of estradiol in women suffering from schizophrenia treated with conventional versus atypical antipsychotics Schizophrenia Research 73 2005 357 366